Agreement to acquire business adds innovative, real-time image recognition technology and expertise to GE HealthCare’s portfolio of AI-enabled devices AI-based technology from Intelligent Ultrasound aims to provide real-time support for OBGYN scans and improve exam accuracy and efficiency Planned acquisition supports GE HealthCare’s precision care strategy to address inefficiencies and […]
Other News
Elucid Commences International PRE-VUE CCT Registry Study
Multi-center, Retrospective Trial to Assess Prognostic Accuracy of Elucid’s Plaque and Plaque-based FFRCT Software in Patients with Clinically Indicated CCTA July 18, 2024 07:05 AM Eastern Daylight Time WASHINGTON & BOSTON–(BUSINESS WIRE)–SCCT2024 – Elucid, a pioneering AI medical technology company providing physicians with imaging analysis software based on ground truth histology to support […]
New Research on Climate Change, Gut Health, and Socioeconomic Status’ Impact on Stroke and Aneurysm Care to Be Presented at Society of NeuroInterventional Surgery’s 21st Annual Meeting
COLORADO SPRINGS, Colo., July 18, 2024 /PRNewswire/ — Neurointerventional surgeons from across the globe will gather at the Society of NeuroInterventional Surgery’s (SNIS) 21st Annual Meeting from July 22 through July 25 in Colorado Springs, Colorado, to present novel research and…
HeartFlow Introduces Next Generation Interactive Plaque Analysis Platform to Assess Patient Risk in Suspected Coronary Artery Disease
Technology offers benefits of HeartFlow Plaque Analysis with the new addition of 3D interactive capabilities, integrated with lesion specific FFRCT values
HFSA Announces Selection of New Officers and Board of Director Members
WASHINGTON, July 18, 2024 /PRNewswire/ — The Heart Failure Society of America (HFSA) recently announced the selection of new officers and board members for the society with terms starting at the conclusion of the HFSA Annual Scientific Meeting 2024 (ASM), which will take place September…
NewAmsterdam Pharma Announces Appointments of Mark C. McKenna and Wouter Joustra to its Board of Directors
NAARDEN, The Netherlands and MIAMI, July 18, 2024 (GLOBE NEWSWIRE) — NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently effective or well-tolerated, today announced the appointments of Mark C. McKenna and Wouter Joustra to its Board of Directors. Mr. McKenna and Mr. Joustra have joined as temporary non-executive directors to fulfill vacant positions within the Board of Directors until their proposed appointment by the general meeting of shareholders at the next annual general meeting. Additionally, NewAmsterdam announced the departure of Sander Slootweg from its Board of Directors, effective July 16, 2024.
Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Portugal
— Portuguese Ministry of Health approves VAZKEPA® (icosapent ethyl) for national reimbursement to reduce the risk of cardiovascular (CV) events in patients with established cardiovascular disease (CVD)1 — — Approval marks eighth national reimbursement of VAZKEPA® in Europe —
Johnson & Johnson reports Q2 2024 results
2024 Second-Quarter reported sales growth of 4.3% to $22.4 Billion with operational growth of 6.6%* and adjusted operational growth of 6.5%*. Adjusted operational growth excluding COVID-19 Vaccine of 7.1%* 2024 Second-Quarter Earnings per share (EPS) of $1.93 decreasing by 5.9% due to one-time special charges and adjusted EPS of $2.82 […]
Imperative Care Announces FDA Clearance and Initial Cases of the Zoom 6F Insert Catheters, the First Insert Catheters Built for Stroke
July 17, 2024 08:00 AM Eastern Daylight Time CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc., today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Zoom™ 6F Insert Catheters, the company’s latest innovation in elevating stroke care and the first insert catheters developed specifically for ischemic stroke procedures. The company […]
At AHRA 2024, Agfa Radiology Solutions highlights intelligent technologies and systems that ensure “One image is all it takes”
MORTSEL, Belgium, July 17, 2024 /PRNewswire/ — At the Annual Meeting of AHRA (the Association for Medical Imaging Management), Agfa Radiology Solutions will demonstrate how its solutions help customers address staffing shortages and tight budgets.
Continue Reading
Agfa’s comprehensive portfolio supports “The Next Generation” in medical imaging by using intelligent and innovative technologies to ensure every X-ray image counts. With accurate and high-quality diagnostic information from the first image taken, retakes are reduced: speeding up workflows and enhancing the experience of radiologist, radiographer and patient.
Agfa Radiology Solutions uses intelligent and innovative technologies to ensure every X-ray image in healthcare counts.
Post this
“We understand the challenges our customers are facing in terms of staffing shortages and decreased budgets. Our productivity features and ‘one image is all it takes’ approach empower each X-ray expert to work more efficiently. Additionally, the DR 100 Essential and VALORY™ are designed to be budget-friendly, but still deliver all the essential functions healthcare facilities need – including our renowned MUSICA® image processing software. They demonstrate our commitment to offering solutions that ensure healthcare facilities never need to compromise on image quality, regardless of their staff and budget constraints,” says Bruce Romaglia, Vice President – North America at Agfa Radiology Solutions.
At Agfa’s booth, visitors can discover solutions and special packages that help bring those advantages to every healthcare organization, whatever their budgets.Intelligent technologies for image processing and workflow assistance:
MUSICA®, which comes standard with all Agfa DR and CR systems, automatically analyses the characteristics of raw images and optimizes the processing parameters, independent of body part or dose deviation. Its high image quality and low-dose features have made MUSICA® the “gold standard” in image processing for radiology departments around the world.
The SmartXR® portfolio adds X-ray intelligence to Agfa’s DR solutions, to provide image acquisition support and lighten the radiographer’s workload. Predictive workflow assistance for dose, alignment, patient positioning, image rotation and more help improve operational performance in image acquisition.
About AgfaAgfa develops, produces and distributes an extensive range of imaging systems and workflow solutions for the printing industry, the healthcare sector, as well as for specific hi-tech industries such as printed electronics & renewable energy solutions.The headquarters are located in Belgium. The largest production and research centers are located in Belgium, the United States, Canada, Germany, France, the United Kingdom, Austria, China and Brazil. Agfa is commercially active worldwide through wholly owned sales organizations in more than 40 countries.For more information on Agfa please visit www.agfa.comFollow us at TwitterAgfa, the Agfa rhombus, MUSICA and SmartXR are trademarks of Agfa-Gevaert N.V. Belgium or its affiliates. All rights reserved.All information contained herein is intended for guidance purposes only, and characteristics of the products and services described in this publication can be changed at any time without notice. Products and services may not be available for your local area. Please contact your local sales representative for availability information. Agfa diligently strives to provide as accurate information as possible, but shall not be responsible for any typographical error.Only the English version of this press release is legally valid. The versions in other languages only represent a translation of the original English version.SOURCE AGFA US Corp.



